First Trust Nasdaq Pharmaceuticals ETF -- Insider Buying Index Registering 16.9%

A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF (FTXH) shows an impressive 16.9% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying Catalent Inc (CTLT), which makes up 3.97% of the First Trust Nasdaq Pharmaceuticals ETF (FTXH), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.